Muthusamy Shanmugam, Head of R&d, COO-novitium Ops: Ani Pharmaceuticals ANIP Planned sale · Filed 25/08/21

Trade details

Type: Planned sale notice
Stock: Ani Pharmaceuticals ANIP
Person: Muthusamy ShanmugamHead of R&d, COO-novitium Ops
Planned sale date: 25/08/21
Filed: 25/08/21

More to sell after $13.1M in 3 months

Ani Pharmaceuticals trades, last 26 weeks

What else happened in Ani Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/22~25/09/20

Muthusamy Shanmugam's recent trades

Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.8M
52,988 sh
$4.8M
Filed 25/08/22
Traded 25/08/21
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.2M
47,012 sh
$4.2M
Filed 25/08/22
Traded 25/08/20
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
Planned saleAni Pharmaceuticals
Planned sale
Ani Pharmaceuticals
ANIP
$4.2M
47,012 sh
$4.2M
Filed 25/08/20
Traded 25/08/20
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.6M
52,990 sh
$4.6M
Filed 25/08/18
Traded 25/08/15
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.2M
47,010 sh
$4.2M
Filed 25/08/18
Traded 25/08/14

Muthusamy Shanmugam, COO — plans to sell 52,988 sh of Ani Pharmaceuticals ANIP · $4.8M · around 08/21 | Whalegun